Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
protein
Biotech
Eikon snaps up clinical pipeline thanks to 'buyer's market'
Eikon Therapeutics is spending some of the more than $600 million its raised on a basket of assets, including three clinical-stage candidates.
Max Bayer
Jun 1, 2023 8:00am
Leaps by Bayer leads $40M Gandeeva funding
Jan 31, 2022 8:00am
Fighting drug-resistant cancer by blocking an escape route
Jan 5, 2022 8:35am
Flagship-incubated Generate reels in $370M for protein therapies
Nov 18, 2021 5:00am
Novartis inks protein degrader deal with new British startup
Nov 2, 2021 5:00am
EQRx's affordable drug drive leads to Absci discovery pact
Oct 6, 2021 8:20am